BridgeMD
New treatment option for Spinal Cord Injuries (SCI)
Official title Effect of Urethral Balloon Dilatation on Urinary Retention After Spinal Cord Injury
ClinicalTrials.gov ID: NCT06978205
What this study is testing
- What it's testing
- Trial Objectives: This clinical trial aims to explore whether ultrasound - guided urethral balloon dilation can effectively improve the micturition function of patients with urinary retention after spinal cord injury, and to evaluate the safety of this treatment method. The main questions it attempts to answer are: Can ultrasound - guided urethral balloon dilation reduce the residual urine volume and improve the quality of life of patients with urinary retention after spinal cord injury?
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 80
You may be able to join if
- Age between 18-80 years old
- There is a confirmed diagnosis report of CT or MRI imaging, with the first diagnosis being spinal cord injury (complete or incomplete), which...
- The spinal shock period has passed, and consciousness is clear with stable vital signs
- In line with the diagnostic criteria of urinary retention and in combination with clinical practice: the patient can urinate autonomously before...
- Urodynamic examination shows maximum urethral pressure greater than 50cmH2O
You likely can't join if
- Patients with severe heart, brain, lung and other important organ diseases or mental and cognitive disorders
- Individuals with disrupted water electrolyte and acid-base balance
- There are serious kidney diseases, bladder fistula surgery, anterior urethral sphincterotomy and other diseases
- There is a urinary system infection
See the full eligibility criteria
- Age between 18-80 years old
- There is a confirmed diagnosis report of CT or MRI imaging, with the first diagnosis being spinal cord injury (complete or incomplete), which conforms to the International Classification of Spinal Cord Injury Neurology...
- The spinal shock period has passed, and consciousness is clear with stable vital signs
- In line with the diagnostic criteria of urinary retention and in combination with clinical practice: the patient can urinate autonomously before spinal cord injury, which is confirmed as spinal cord injury by clinical...
- Urodynamic examination shows maximum urethral pressure greater than 50cmH2O
- No tumors or benign prostatic hyperplasia were found
- Patients who have had their indwelling urinary catheter removed
- Voluntary participation in research and signing of informed consent form
- Patients with severe heart, brain, lung and other important organ diseases or mental and cognitive disorders
- Individuals with disrupted water electrolyte and acid-base balance
- There are serious kidney diseases, bladder fistula surgery, anterior urethral sphincterotomy and other diseases
- There is a urinary system infection
The study team makes the final eligibility decision.
Where it's taking place
- Jinan, Shandong, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Jinan, Shandong, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.